New prevention technologies for respiratory distress syndrome in premature infants will be introduced in the perinatal centers of the country.
The technology is based on the use of surfactant, a substance which begins to be produced in the body by 30-32 week of pregnancy. If the child is born before the end of 32 weeks, the amount of surfactant in the body is usually not enough for normal breathing. Most of these newborns die due to respiratory insufficiency.
However, modern health care technologies help overcome this critical condition. The most effective way in the last ten years has proved to be the use of drugs, based on sulfaktant, that can compensate for the lack of this substance in the body and normalize the breathing process.
This practice will be introduced in the perinatal centers of the capital. 50 vials of the drug will be bought. In the future, we plan to introduce the technology in all the perinatat centers of the capital. According to the Ministry of Health, the introduction of this technology will further reduce neonatal, infant and child mortality.